Nalagenetics is a medtech company focused on the personalization of dosing and prescription. Our mission is to provide actionable and cost-effective pharmacogenomics testing for developing countries, starting with Asia. Adverse drug reactions (ADR) cause 8-12% of hospital admissions and is the 4th leading cause of death in the US. Although 30-70% of ADR have genetic associations, genetic testing for drug response in developing countries is not widely adopted because it is too expensive and unproven in local populations. Thus, we develop an affordable and actionable pharmacogenomics testing backed with clinical decision support to aggregate real-world-evidence data for a better prescription.